Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
Role of Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning From Mechanical Ventilation
1 other identifier
observational
55
1 country
1
Brief Summary
The aim of this study is to assess the validity of the diaphragmatic thickening Fraction measured by ultrasound as a predictor for successful weaning from mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedStudy Start
First participant enrolled
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedMay 29, 2025
May 1, 2025
10 months
June 13, 2024
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diaphragmatic thickening Fraction as predictor for weaning from mechanical ventilation.
assess the validity of the diaphragmatic thickening Fraction measured by ultrasound as a predictor for successful weaning from mechanical ventilation.
Baseline and after 6 month
Eligibility Criteria
Adult patients \>18 years old, who are in need for mechanical ventilation as: Life threatening hypoxia, Respiratory rate \> 30 breath/min, Disturbed conscious level.
You may qualify if:
- Adult patients \>18 years old, who are in need for mechanical ventilation as: Life threatening hypoxia, Respiratory rate \> 30 breath/min, Disturbed conscious level.
You may not qualify if:
- Age \<18 years.
- Pregnancy
- Surgical incisions likely to interfere with ultrasound examination.
- Hepato-splenomegaly, Ascites
- Neuromuscular disease as Myasthenia gravis, kypho-scoliosis
- Diaphragmatic Paralysis (paralyzed diaphragm exhibiting abnormal paradoxical movement, i.e., moving in a cranial direction during inspiration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mohamed AbdElmoniem
Al Mansurah, 35516, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed AbdElmoniem
Mansoura University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of chest medicine
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 18, 2024
Study Start
September 5, 2024
Primary Completion
July 15, 2025
Study Completion
December 15, 2025
Last Updated
May 29, 2025
Record last verified: 2025-05